08-Feb-17 Smith & Nephew reported a 7 percent drop in profit, as tough conditions in China and Saudi Arabia kept growth in check. The company has focused on emerging markets in recent years to boost sluggish demand in the US and Europe, where it competes with Zimmer and Stryker. The company delivered growth, but not at the level it had wanted. [image: Smith & Nephew]

08-Feb-17 In 2016, nearly 300,000 foreign patients are estimated to have traveled to the US to seek medical treatments, according to Josef Woodman of Patients Beyond Borders. To entice medical travelers, top medical centers have been spending millions of dollars cultivating their facilities to attract international patients, Woodman noted. More recently, they are seeing a growing influx of patients from China. [image: PYMNTS.com]

01-Feb-17 Malaysia is a popular destination for tourists from the Middle East, with nearly 200,000 arriving in 2016. The country is a key destination for medical tourism. In neighboring Thailand, tourism officials said the US ban could lift visitor numbers. "The Middle East is a big market for us, especially in the medical tourism sector," said Tourism Authority Governor Yuthasak Supasorn. [image: Reuters]

01-Feb-17 The Middle East region, which includes some countries that are a target of Trump's ban, is the top source of patients who travel to the US for medical care. The travel ban could prompt international patients to skip the US and take their dollars elsewhere, such as to Germany or Thailand. [image: Wikimedia Commons]

26-Jan-17 The medical and surgical aesthetics market grew a further 8.3 percent in 2016. Representing 46 percent of global market share, the USA still leads the way, followed by Europe, Asia-Pacific and Latin America, according to annual figures from IMCAS. Global growth is above all driven by Asia, which saw annual growth of 10 percent in 2016. [image: The Malay Mail Online]